Informed Conditioning on Clinical Covariates Increases Power in Case-Control Association Studies
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Genetic case-control association studies often include data on clinical covariates, such as body mass index (BMI), smoking status, or age, that may modify the underlying genetic risk of case or control samples. For example, in type 2 diabetes, odds ratios for established variants estimated from low-BMI cases are larger than those estimated from high-BMI cases. An unanswered question is how to use this information to maximize statistical power in case-control studies that ascertain individuals on the basis of phenotype (case-control ascertainment) or phenotype and clinical covariates (case-control-covariate ascertainment). While current approaches improve power in studies with random ascertainment, they often lose power under case-control ascertainment and fail to capture available power increases under case-control-covariate ascertainment. We show that an informed conditioning approach, based on the liability threshold model with parameters informed by external epidemiological information, fully accounts for disease prevalence and non-random ascertainment of phenotype as well as covariates and provides a substantial increase in power while maintaining a properly controlled false-positive rate. Our method outperforms standard case-control association tests with or without covariates, tests of gene x covariate interaction, and previously proposed tests for dealing with covariates in ascertained data, with especially large improvements in the case of case-control-covariate ascertainment. We investigate empirical case-control studies of type 2 diabetes, prostate cancer, lung cancer, breast cancer, rheumatoid arthritis, age-related macular degeneration, and end-stage kidney disease over a total of 89,726 samples. In these datasets, informed conditioning outperforms logistic regression for 115 of the 157 known associated variants investigated (P-value = 1 × 10(-9)). The improvement varied across diseases with a 16% median increase in χ(2) test statistics and a commensurate increase in power. This suggests that applying our method to existing and future association studies of these diseases may identify novel disease loci.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., Perry, J. R. B., Elliott, K. S., Lango, H., Rayner, N. W., et al. (2007) · Science · doi:10.1126/science.1141634 · Cited by 4,531
A new multipoint method for genome-wide association studies by imputation of genotypes
Marchini, J., Howie, B., Myers, S., McVean, G., & Donnelly, P. (2007) · Nature Genetics · doi:10.1038/ng2088 · Cited by 2,609
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028 · cited 1×
“…with age as a covariate, breast cancer [44,45] with age as a covariate, rheumatoid arthritis [46] with age and sex as covariates, age-related macular degeneration [47] with age as a covariate, and end-stage kidney disease [48] (ESKD) with age as a covariate (Tables 4–5 and Tables S5,S11–S15).”
Self-citationThe Importance of the Normality Assumption in Large Public Health Data Sets
Lumley, T., Diehr, P., Emerson, S., & Chen, L. (2002) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.23.100901.140546 · Cited by 1,803
All of Statistics: A Concise Course in Statistical Inference
Wasserman, L. (2004) · Springer Texts in Statistics · doi:10.1007/978-0-387-21736-9 · Cited by 1,090
Myocardial Infarction Genetics Consortium (2009) · Nature Genetics · doi:10.1038/ng.327 · Cited by 1,088
Estimating Missing Heritability for Disease from Genome-wide Association Studies
Lee, S. H., Wray, N. R., Goddard, M. E., & Visscher, P. M. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.02.002 · Cited by 1,064 · cited 2×
“The relationship between modeling disease on the liability threshold and dichotomous scale has been examined by [23] as well as [24,25] in the context of computing the area under the receiver operator curve (AUC), estimating risks, and the distribution of disease in a population.”
Data and Theory Point to Mainly Additive Genetic Variance for Complex Traits
Hill, W. G., Goddard, M. E., & Visscher, P. M. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000008 · Cited by 1,039
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men
Freedman, M. L., Haiman, C. A., Patterson, N., McDonald, G. J., Tandon, A., Waliszewska, A., Penney, K., Steen, R. G., Ardlie, K., John, E. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605832103 · Cited by 612 · cited 1×
“Higher genetic risk in early-onset cases has been shown empirically for prostate and breast cancers [2,3], and has also been hypothesized for other diseases [4,5].”
Self-citationExploiting Gene-Environment Interaction to Detect Genetic Associations
Kraft, P., Yen, Y.-C., Stram, D. O., Morrison, J., & Gauderman, W. J. (2007) · Human Heredity · doi:10.1159/000099183 · Cited by 439
Self-citationThe genetic interpretation of area under the ROC curve in genomic profiling
Wray, N. R., Yang, J., Goddard, M. E., & Visscher, P. M. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000864 · Cited by 334 · cited 2×
“The relationship between modeling disease on the liability threshold and dichotomous scale has been examined by [23] as well as [24,25] in the context of computing the area under the receiver operator curve (AUC), estimating risks, and the distribution of disease in a population.”
A rare penetrant mutation in CFH confers high risk of age-related macular degeneration
Raychaudhuri, S., Iartchouk, O., Chin, K., Tan, P. L., Tai, A. K., Ripke, S., Gowrisankar, S., Vemuri, S., Montgomery, K., Yu, Y., et al. (2011) · Nature Genetics · doi:10.1038/ng.976 · Cited by 323 · cited 1×
“Recent studies of age-related macular degeneration [61] and gout [62] found increased odds ratios estimated from younger cases and genetic associations to age of onset, which is consistent with the LT model.”
Hamza, T. H., Chen, H., Hill-Burns, E. M., Rhodes, S. L., Montimurro, J., Kay, D. M., Tenesa, A., Kusel, V. I., Sheehan, P., Eaaswarkhanth, M., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002237 · Cited by 218
Waters, K. M., Stram, D. O., Hassanein, M. T., Le Marchand, L., Wilkens, L. R., Maskarinec, G., Monroe, K. R., Kolonel, L. N., Altshuler, D., Henderson, B. E., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001078 · Cited by 191 · cited 3×
“We examined the performance of the same six statistics over of 6,142 cases and 7,403 controls genotyped at 19 known associated SNPs from the Multiethnic Cohort (MEC) (African Americans, Latinos, Japanese Americans, Native Hawaiians, and European Americans) [38].”
Self-citationIncluding known covariates can reduce power to detect genetic effects in case-control studies
Pirinen, M., Donnelly, P., & Spencer, C. C. A. (2012) · Nature Genetics · doi:10.1038/ng.2346 · Cited by 117 · cited 2×
“For T2D and prostate cancer alone, we identified 29 recent studies published in Nature Genetics (see Text S1 in File S1) that would benefit from application of our method.”
Power of Selective Genotyping in Genetic Association Analyses of Quantitative Traits
Van Gestel, S., Houwing-Duistermaat, J. J., Adolfsson, R., van Duijn, C. M., & Van Broeckhoven, C. (2000) · Behavior Genetics · doi:10.1023/a:1001907321955 · Cited by 108
Cited by
Genome-wide association studies
Uffelmann, E., Huang, Q. Q., Munung, N. S., de Vries, J., Okada, Y., Martin, A. R., Martin, H. C., Lappalainen, T., & Posthuma, D. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00056-9 · Cited by 1,849
Advantages and pitfalls in the application of mixed-model association methods
Yang, J., Zaitlen, N. A., Goddard, M. E., Visscher, P. M., & Price, A. L. (2014) · Nature Genetics · doi:10.1038/ng.2876 · Cited by 981
Self-citationSequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico
The SIGMA Type 2 Diabetes Consortium (2014) · Nature · doi:10.1038/nature12828 · Cited by 507
Adjusting for Heritable Covariates Can Bias Effect Estimates in Genome-Wide Association Studies
Aschard, H., Vilhjálmsson, B. J., Joshi, A. D., Price, A. L., & Kraft, P. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.12.021 · Cited by 287
“However, this analysis was conducted on case-control data, ascertained to oversample T2D cases, raising additional complexities in the interpretation of these results.(4,18) Several other large-scale heritable-trait-adjusted GWAS have been conducted.”
Self-citationPopulation structure in genetic studies: Confounding factors and mixed models
Sul, J. H., Martin, L. S., & Eskin, E. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007309 · Cited by 262
Metadata
- Authors
- Zaitlen, N., Lindström, S., Pasaniuc, B., Cornelis, M., Genovese, G., Pollack, S., Barton, A., Bickeböller, H., Bowden, D. W., Eyre, S., Freedman, B. I., Friedman, D. J., Field, J. K., Groop, L., Haugen, A., Heinrich, J., Henderson, B. E., Hicks, P. J., Hocking, L. J., Kolonel, L. N., Landi, M. T., Langefeld, C. D., Le Marchand, L., Meister, M., Morgan, A. W., Raji, O. Y., Risch, A., Rosenberger, A., Scherf, D., Steer, S., Walshaw, M., Waters, K. M., Wilson, A. G., Wordsworth, P., Zienolddiny, S., Tchetgen, E. T., Haiman, C., Hunter, D. J., Plenge, R. M., Worthington, J., Christiani, D. C., Schaumberg, D. A., Chasman, D. I., Altshuler, D., Voight, B., Kraft, P., Patterson, N., & Price, A. L.
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-11-08
- Volume
- 8
- Issue
- 11
- Pages
- e1003032
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- OpenAlex
- W2146289468
- Cited by
- 85
- References
- 16
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.